33 related articles for article (PubMed ID: 15709164)
21. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
[TBL] [Abstract][Full Text] [Related]
25. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects.
García-Ramírez M; Hernández C; Simó R
Diabetes Care; 2008 Jun; 31(6):1189-94. PubMed ID: 18332162
[TBL] [Abstract][Full Text] [Related]
26. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.
Dagnon K; Pacary E; Commo F; Antoine M; Bernaudin M; Bernaudin JF; Callard P
Clin Cancer Res; 2005 Feb; 11(3):993-9. PubMed ID: 15709164
[TBL] [Abstract][Full Text] [Related]
27. Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.
Merelli A; Caltana L; Lazarowski A; Brusco A
Drug Metabol Drug Interact; 2011; 26(2):65-9. PubMed ID: 21756166
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid receptor expression abnormalities in lung cancer: important clues or major obstacles?
Minna JD; Mangelsdorf DJ
J Natl Cancer Inst; 1997 May; 89(9):602-4. PubMed ID: 9150178
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]